Inventor · disambiguated record
David W. Russell
Also filed as: RUSSELL DAVID W · RUSSELL DAVID WILLIAM
21 granted patents·9 pending applications·1,283 citations·filing 1984–2023
96Inventor score
Files withUNIV TEXAS12RUSSELL DAVID W4UNIV WASHINGTON3UNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION3CHILDRENS HOSPITAL MED CT2
Top patents by PatentIndex Score
30 records- 0194US6156303AAdeno-associated virus (AAV) isolates and AAV vectors derived therefromUNIV WASHINGTON·Filed 1997·Granted Dec 5, 2000·781 cites·32 claims
- 0291US8846387B2Targeted gene modification by parvoviral vectorsRUSSELL DAVID W·Filed 2011·Granted Sep 30, 2014·18 cites·20 claims
- 0391US4935363ASterol regulatory elementsUNIV TEXAS·Filed 1987·Granted Jun 19, 1990·94 cites·16 claims
- 0488US5604090AMethod for increasing transduction of cells by adeno-associated virus vectorsHUTCHINSON FRED CANCER RES·Filed 1994·Granted Feb 18, 1997·113 cites·30 claims
- 0586US8105831B2Parvoviral production of HLA homozygous cellsRUSSELL DAVID W·Filed 2008·Granted Jan 31, 2012·9 cites·7 claims
- 0685US5695963AEndothelial PAS domain proteinUNIV TEXAS·Filed 1997·Granted Dec 9, 1997·47 cites·11 claims
- 0783US11813318B2Beta-2 microglobulin-deficient cellsUNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION·Filed 2019·Granted Nov 14, 2023·1 cites·16 claims
- 0881US8586358B2HLA homozygous cellsRUSSELL DAVID W·Filed 2011·Granted Nov 19, 2013·3 cites·9 claims
- 0977US2024207378A1Beta-2 microglobulin-deficient cellsUNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION·Filed 2023·Application pending·0 cites
- 1076US7972856B2Targeted gene modification by parvoviral vectorsUNIV WASHINGTON·Filed 2003·Granted Jul 5, 2011·4 cites·34 claims
- 1176US5834182AMethod for increasing transduction of cells by adeno-associated virus vectorsHUTCHINSON FRED CANCER RES·Filed 1995·Granted Nov 10, 1998·34 cites·9 claims
- 1272US5861248ABiomarkers for detection of prostate cancerUNIV TEXAS·Filed 1996·Granted Jan 19, 1999·36 cites·15 claims
- 1368US2022056477A1Foamy viral vector compositions and methods for the manufacture of sameCHILDRENS HOSPITAL MED CT·Filed 2021·Application pending·0 cites
- 1465US2020149065A1Foamy viral vector compositions and methods for the manufacture of sameCHILDRENS HOSPITAL MED CT·Filed 2019·Application pending·0 cites
- 1564US5378603AMethod and composition for identifying substances which activate transcription of the LDL receptor geneUNIV TEXAS·Filed 1987·Granted Jan 3, 1995·20 cites·11 claims
- 1663US5422262ASteroid 5a reductase nucleic acid segments and recombinant vectors and host cellsUNIV TEXAS·Filed 1991·Granted Jun 6, 1995·34 cites·43 claims
- 1761US5840532ANeuronal bHLH-PAS domain proteinsUNIV TEXAS·Filed 1997·Granted Nov 24, 1998·11 cites·4 claims
- 1860US6090559ABiomarkers for the detection of prostate cancerUROCOR INC·Filed 1998·Granted Jul 18, 2000·18 cites·7 claims
- 1959US5679521ASteroid 5A-reductasesUNIV TEXAS·Filed 1995·Granted Oct 21, 1997·11 cites·13 claims
- 2055US5256545ASterol Regulatory ElementsUNIV TEXAS·Filed 1989·Granted Oct 26, 1993·12 cites·24 claims
- 2155US4745060AMethods and compositions for the detection of Familial HypercholesterolemiaUNIV TEXAS·Filed 1984·Granted May 17, 1988·11 cites·21 claims
- 2255US2022106596A1A method of gene editingUNIV WASHINGTON·Filed 2020·Application pending·0 cites
- 2354US2016257972A1Foamy viral vector compositions and methods for the manufacture of sameCHILDREN'S HOSPITAL MEDICAL CENTER·Filed 2016·Application pending·0 cites
- 2452US2019365876A1HLA Class II Deficient Cells, HLA Class I Deficient Cells Capable of Expressing HLA Class II Proteins, and Uses ThereofUNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION·Filed 2019·Application pending·0 cites
- 2552US2014134195A1Beta-2 microglobulin-deficient cellsRUSSELL DAVID W·Filed 2012·Application pending·0 cites
- 2651US2023303658A1Human non-naturally occurring modified fc region of igg specifically binding to non-naturally occurring modified fc receptorASTELLAS PHARMA INC·Filed 2021·Application pending·0 cites
- 2750US2015056225A1HLA Class II Deficient Cells, HLA Class I Deficient Cells Capable of Expressing HLA Class II Proteins, and Uses ThereofUNIV WASHINGTON CT COMMERCIALI·Filed 2013·Application pending·0 cites
- 2848US6562609B1Cholesterol 25-hydroxylaseUNIV TEXAS·Filed 1998·Granted May 13, 2003·9 cites·28 claims
- 2947US5215910AHost cells transformed with sterol regulatory elementsUNIV TEXAS·Filed 1990·Granted Jun 1, 1993·8 cites·8 claims
- 3047US4966837AMethods and compositions for the detection of familial hypercholesterolemiaUNIV TEXAS·Filed 1986·Granted Oct 30, 1990·9 cites·26 claims
Join the waitlist — get patent alerts
Get an alert when David W. Russell files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →